More Island Pharmaceuticals Ltd news
Island Pharmaceuticals LtdASX: ILA

USAMRIID Marburg study advances towards dosing

Oct 18, 2026 at 6:31 PM EDT · Issued by Island Pharmaceuticals Ltd

Filed with ASX · Oct 18, 2026 at 6:31 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/usamriid-marburg-study-advances-towards-dosing

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

  • Galidesivir GMP manufacturing commencesOct 1
  • Pivotal Marburg data secured for Galidesivir FDA pathwayAug 30
  • Island boosts Galidesivir supply as Ebola surgesAug 20
  • Texas Biomed SOW accelerates pivotal FDA pathwayJul 12
  • Investor Presentation - Ebola Clinical ProgramJul 7
All Island Pharmaceuticals news releases↗

Follow Island Pharmaceuticals into a list and get an email when it puts out news.

Follow Island Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer